RxDoctor Payments Data

Morgan Arrington, PA

Physician Assistant · Smithfield, VANPI 1538651716

Payments from drug & device makers

$1,178in general payments, 2019–2025

Across 65 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$319
  • Boehringer Ingelheim$154
  • Lilly USA, LLC$152
  • Nestle Healthcare Nutrition Inc.$138
  • AbbVie$68
  • Dexcom, Inc.$59
  • plus $288 from 12 others

What the payments were for

  • Food & beverage$1,178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,178 in reported general payments places this provider in the 75th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$2,719
Medicare patients
105
Services billed
238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide98$135,183
OzempicSemaglutide79$106,176
JardianceEmpagliflozin74$97,269
EliquisApixaban67$60,849
FarxigaDapagliflozin Propanediol67$58,009
XareltoRivaroxaban34$32,308
JanuviaSitagliptin Phosphate32$24,039
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$22,464
MounjaroTirzepatide19$19,974
MyrbetriqMirabegron25$19,533
GemtesaVibegron13$13,725
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$13,425
Breo ElliptaFluticasone/Vilanterol12$12,989
TradjentaLinagliptin15$12,281
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog18$10,195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$152$155,157117 claims
Boehringer IngelheimJardiance, Tradjenta$154$109,55089 claims
Novo NordiskOzempic$319$106,17679 claims
GSKTrelegy Ellipta, Breo Ellipta$25$35,45343 claims
Johnson & JohnsonXarelto$16$32,30834 claims
Sumitomo Pharma America, Inc.Gemtesa$36$13,72513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Smithfield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →